Alaska committee hears Washington, Colorado reports on public-option plans as possible tools to curb premiums

ANCHORAGE — State and national healthcare experts told the Alaska House Labor and Commerce Committee on Feb. 23 that public-option programs — the state-level plans designed to expand affordable private coverage — show promise for lowering premiums and out-of-pocket costs, but that Alaska would need tailored design and careful coordination with providers.

The committee heard a three-state briefing. Laura Kate Zajikin, director of market competition and affordability at the Washington Health Benefit Exchange, outlined Washington’s Cascade Select public option and said the program uses a competitive procurement model and an aggregate provider reimbursement cap to restrain premiums. "Public option in Washington State is not a state-run health insurance program," Zajikin said. "Instead, it promotes healthy competition among private insurance carriers who are voluntarily offering public option plans on [the] exchange." She noted a statewide aggregate provider cap (160% of Medicare) and hospital participation rules as central levers of the design.

Why it matters: presenters described tradeoffs that matter in Alaska, where the market is small and provider availability is limited. Dan Muse of Princeton’s State Health and Value Strategies said governments typically choose among three pathways — reimbursement limits tied to Medicare rates, premium-savings targets like Colorado’s, or a public buy-in to an existing public program — and each requires different regulatory and federal waiver work. "A government can use either regulatory or purchasing power or a combination of the two to lower costs and extend access," Muse said.

Experts’ evidence and cautions: Zajikin said Cascade Select plans have been a low-premium option on Washington’s exchange and that enrollment rose as price competition grew. Adam Fox of the Colorado Consumer Health Initiative described Colorado’s mandatory-option structure and said the state paired premium-reduction targets with reimbursement floors and a 1332 waiver that redirected federal savings into state premium assistance; he reported Colorado reached about 50% enrollment in option plans in 2026. "We see enrollment growth and measurable reductions in out-of-pocket spending for enrollees," Fox said.

Panelists warned that lowering provider reimbursement can narrow networks if hospitals or health systems decline to participate. Muse and Zajikin recommended explicit hospital participation rules, careful calibration of reimbursement floors and interagency coordination when multiple state authorities share responsibilities.

Questions from committee members focused on whether Alaska’s Pacific Health Coalition and small-employer market could play a role, how premium subsidies interact with lowered benchmark premiums, and the feasibility of capturing federal dollars via waivers. Zajikin and Muse said some steps — such as using existing purchasing authorities and designing standardized benefits — can be taken without immediately standing up a state-based marketplace, but that capturing federal savings to fund state subsidies typically requires a 1332 waiver and, in many cases, a state-based exchange.

What’s next: Chair Fields proposed a follow-up hearing to evaluate which elements from Washington and Colorado might be feasible in Alaska and requested additional written materials and comparisons from the presenters.

The committee then moved to the next agenda item, HB 293 (genetic counseling), which the panel took up after the presentations.